Blue Shield of California Promise Health Plan prior authorization, page 4

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
81223CFTR GENE ANALYSIS FULL GENE SEQUENCEMedi-Cal Prior Authorization List, Pg 7 Original policy
81225CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *8, *17)Medi-Cal Prior Authorization List, Pg 7 Original policy
81226CYP2D6 gene analysis, common variantsMedi-Cal Prior Authorization List, Pg 7 Original policy
81231CYP3A5 (cytochrome P450 family 3 subfamily A member 5), gene analysis, common variantsMedi-Cal Prior Authorization List, Pg 7 Original policy
81232DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism), gene analysis, common variant(s) (eg, *2A, *4, *5, *6)Medi-Cal Prior Authorization List, Pg 7 Original policy
81233GENE ANALYSIS BRUTON'S TYROSINE KINASE COMMONMedi-Cal Prior Authorization List, Pg 7 Original policy
81234GENE ANALYSIS DM1 PROTEIN KINASE ABNORMAL ALLELEMedi-Cal Prior Authorization List, Pg 7 Original policy
81235EGFR (Epidermal Growth Factor Receptor) Gene Analysis, Common VariantsMedi-Cal Prior Authorization List, Pg 7 Original policy
81236GENE ANALYSIS ZESTE 2 FULL SEQUENCEMedi-Cal Prior Authorization List, Pg 7 Original policy
81237GENE ANALYSIS ZESTE 2 COMMON VARIANTSMedi-Cal Prior Authorization List, Pg 7 Original policy
81238F9 FULL GENE SEQUENCEMedi-Cal Prior Authorization List, Pg 7 Original policy
81239GENE ANALYSIS DM1 PROTEIN KINASE CHARAC ALLELESMedi-Cal Prior Authorization List, Pg 7 Original policy
81243FMR1 GENE DETECTIONMedi-Cal Prior Authorization List, Pg 7 Original policy
81245FLT3 GENEMedi-Cal Prior Authorization List, Pg 7 Original policy
81246FLT3 GENE ANALYSISMedi-Cal Prior Authorization List, Pg 7 Original policy
81247G6PD (glucose-6-phosphate dehyfrogenase), gene analysis; common variant(s)Medi-Cal Prior Authorization List, Pg 7 Original policy
81250G6PC GENEMedi-Cal Prior Authorization List, Pg 7 Original policy
81256HFE HEMOCHROMATOSIS GENE ANAL COMMON VARIANTSMedi-Cal Prior Authorization List, Pg 7 Original policy
81257HBA1/HBA2 GENEMedi-Cal Prior Authorization List, Pg 7 Original policy
81258HBA1 HBA2 GENE KNOWN VARIANTMedi-Cal Prior Authorization List, Pg 7 Original policy
81259HBA1 HBA2 GENE ANAL FULL GENE SEQMedi-Cal Prior Authorization List, Pg 8 Original policy
81260IKBKAP GENEMedi-Cal Prior Authorization List, Pg 8 Original policy
81265STR MARKERS SPECIMEN ANALMedi-Cal Prior Authorization List, Pg 8 Original policy
81266STR MARKERS SPEC ANAL ADDLMedi-Cal Prior Authorization List, Pg 8 Original policy
81267CHIMERISM ANAL NO CELL SELECMedi-Cal Prior Authorization List, Pg 8 Original policy
81268CHIMERISM ANAL W/CELL SELECTMedi-Cal Prior Authorization List, Pg 8 Original policy
81269HBA1 HBA2 GENE ANAL DUP DEL VARIANTMedi-Cal Prior Authorization List, Pg 8 Original policy
81271GENE ANALYSIS HUNTINGTIN FOR ABNORMAL ALLELESMedi-Cal Prior Authorization List, Pg 8 Original policy
81272KIT GENE TARGETED SEQ ANALYSMedi-Cal Prior Authorization List, Pg 8 Original policy
81273KIT GENE ANALYS D816 VARIANTMedi-Cal Prior Authorization List, Pg 8 Original policy
81274GENE ANALYSIS HUNTINGTIN FOR CHARAC ALLELESMedi-Cal Prior Authorization List, Pg 8 Original policy
81275KRAS GENE VARIANTS EXON 2Medi-Cal Prior Authorization List, Pg 8 Original policy
81276KRAS GENE ADDL VARIANTSMedi-Cal Prior Authorization List, Pg 8 Original policy
81277CYTOGENOMIC NEOPLASIA GENOME-WIDE MICROARRAY ANALYSIS INTERROGATIONMedi-Cal Prior Authorization List, Pg 8 Original policy
81278BREAKPOINT REGION (MBR) AND MINOR CLUSTER REGION (MCR) BREAKPOINTSMedi-Cal Prior Authorization List, Pg 8 Original policy
81283IFNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variantMedi-Cal Prior Authorization List, Pg 8 Original policy
81284GENE ANALYSIS FRATAXIN FOR ABNORMAL ALLELESMedi-Cal Prior Authorization List, Pg 8 Original policy
81285GENE ANALYSIS FRATAXIN FOR CHARACTER ALLELESMedi-Cal Prior Authorization List, Pg 8 Original policy
81286GENE ANALYSIS FRATAXIN OF FULL SEQUENCEMedi-Cal Prior Authorization List, Pg 8 Original policy
81287MGMT PROMOTER METHYLATION ANALYSISMedi-Cal Prior Authorization List, Pg 8 Original policy
81288MLH1 GENEMedi-Cal Prior Authorization List, Pg 8 Original policy
81289GENE ANALYSIS FRATAXIN FOR KNOWN FAMILIAL VARIANTSMedi-Cal Prior Authorization List, Pg 8 Original policy
81301MICROSATELLITE INSTABILITYMedi-Cal Prior Authorization List, Pg 8 Original policy
81305GENE ANALYSIS FOR P.LEU265PRO VARIANTMedi-Cal Prior Authorization List, Pg 8 Original policy
81306NUDT15 (nudix hydrolase 15) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *3, *4, *5, *6)Medi-Cal Prior Authorization List, Pg 8 Original policy
81309PIK3CA PHOSPHATIDYLINOSITOL-4 5-BIPHOSPHATE 3-KINASE CATALYTIC SUBUNIT ALPHAMedi-Cal Prior Authorization List, Pg 8 Original policy
81310NPM1 GENEMedi-Cal Prior Authorization List, Pg 8 Original policy
81311NRAS GENE VARIANTS EXON 2&3Medi-Cal Prior Authorization List, Pg 8 Original policy
81312GENE ANALYSIS POLY[A] BIND PROTEIN NUCL 1 ABNORMMedi-Cal Prior Authorization List, Pg 8 Original policy
81314PDGFRA GENEMedi-Cal Prior Authorization List, Pg 8 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.